Drug
Ticagrelor clinical trials
Also written Brilinta, Brilique and AZD6140.
- studies test it
- 294
- open now
- 27
- in phase 3
- 74
- first study started
- 2006
Keep track of what changes. Save the Ticagrelor studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
294 studies that test it; most in 2014 (51)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 7 |
| 2012 | 26 |
| 2013 | 31 |
| 2014 | 51 |
| 2015 | 43 |
| 2016 | 17 |
| 2017 | 20 |
| 2018 | 18 |
| 2019 | 12 |
| 2020 | 9 |
| 2021 | 12 |
| 2022 | 12 |
| 2023 | 7 |
| 2024 | 12 |
| 2025 | 1 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 31
- Phase 2
- 39
- Phase 3
- 74
- Phase 4
- 144
- No phase
- 19
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 48 · Other 246
AstraZeneca (40) · University of Florida (14) · University of Patras (12) · Kafrelsheikh University (10) · First Affiliated Hospital of Harbin Medical University (9) · Collegium Medicum w Bydgoszczy (5) · Dong-A University (5) · Ottawa Heart Institute Research Corporation (4)
Often tested with
Tested in the same studies.
Clopidogrel (51) · Aspirin (32) · Prasugrel (31) · Rivaroxaban (6) · Cilostazol (6) · Rosuvastatin (3) · Cangrelor (2) · Eptifibatide (2)
Studies
Open first, then newest update. How each study uses Ticagrelor is read from its arms, and is right about nine times in ten.
Testing it · 294
- Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery DiseaseNot yet recruitingPhase 4University of MessinaNCT07080684Written as Ticagrelor 60 mg
- TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled StudyNot yet recruitingPhase 3University Hospital, ToulouseNCT07821008Written as Experimental group: ticagrelor
- Personalizing Thromboprophylaxis for Patients With Peripheral Artery DiseaseRecruitingNot applicableMassachusetts General HospitalNCT07613840Written as Ticagrelor
- Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 MonthsRecruitingPhase 4Instituto de Investigación Sanitaria de la Fundación Jiménez DíazNCT07507500Written as Ticagrelor
- Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve ImplantationRecruitingPhase 4Fundacin Biomedica Galicia SurNCT05283356Written as Ticagrelor 60mg
- Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCIRecruitingPhase 4Medical University of GdanskNCT04695106Written as Ticagrelor
- Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.RecruitingPhase 3Cardiocentro TicinoNCT07582835Written as Ticagrelor
- Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy VolunteersNot yet recruitingPhase 1Advenchen Laboratories Nanjing Ltd.NCT07438886Written as Ticagrelor Tablets
- Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary InterventionRecruitingPhase 4University of FloridaNCT06228456Written as Ticagrelor 60mg
- One-Month DAPT in CABG PatientsRecruitingPhase 3Weill Medical College of Cornell UniversityNCT05997693Written as Ticagrelor 90 MG
- Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIARecruitingPhase 3Kafrelsheikh UniversityNCT06591377Written as Ticagrelor 90 MG
- Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to AtherosclerosisRecruitingPhase 3Assistance Publique - Hôpitaux de ParisNCT05476991Written as Ticagrelor 90mg
- Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIARecruitingPhase 3Kafrelsheikh UniversityNCT06591338Written as Ticagrelor 90 MG
- Ticagrelore Alone Post PCIRecruitingPhase 4Shiraz University of Medical SciencesNCT06509893Written as Ticagrelor 90 MG
- Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIARecruitingPhase 3Kafrelsheikh UniversityNCT06591312Written as Ticagrelor 90 MG
- Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIARecruitingPhase 3Kafrelsheikh UniversityNCT06591390Written as Ticagrelor 90 MG
- Ticagrelor Versus Cilostazol in Ischemic StrokeRecruitingPhase 3Kafrelsheikh UniversityNCT06561867Written as Ticagrelor 90 MG
- Ticagrelor Versus Cilostazol in Large-vessel Ischemic StrokeRecruitingPhase 3Kafrelsheikh UniversityNCT06202755Written as Ticagrelor 90 MG
- Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIARecruitingPhase 3Kafrelsheikh UniversityNCT06196047Written as Ticagrelor 90 MG
- Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary InterventionRecruitingPhase 4Fu Wai Hospital, Beijing, ChinaNCT04240834Written as Ticagrelor
See all 294 studies that test Ticagrelor →
Given in every arm · 27 — Ticagrelor is usual care beside what is tested
- IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary SyndromeRecruitingPhase 4Shanghai Zhongshan HospitalNCT06451198Written as Ticagrelor
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICADRecruitingNot applicableSunnybrook Health Sciences CentreNCT06714526Written as ticagrelor + aspirin
- Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial HaemorrhageActive, not recruitingNot applicableRadboud University Medical CenterNCT05986968Written as Ticagrelor
- The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to EndotoxinCompletedPhase 4Sheffield Teaching Hospitals NHS Foundation TrustNCT03869268Written as Ticagrelor
- Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy SubjectsCompletedPhase 1Tianjin Institute of Pharmaceutical Research Co., LtdNCT06584812Written as Ticagrelor
- P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable ScaffoldTerminatedPhase 4Samsung Medical CenterNCT03119012Written as Ticagrelor
- Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery LesionsActive, not recruitingNot applicableXijing HospitalNCT05209412Written as Ticagrelor
- GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent ImplantationCompletedPhase 3ECRI bvNCT01813435Written as Ticagrelor
- GM03 - Platelet RNA Signatures of AspirinCompletedEarly Phase 1Duke UniversityNCT05278637Written as Ticagrelor
- Tailored Antiplatelet Therapy Following PCICompletedPhase 4Mayo ClinicNCT01742117Written as Ticagrelor
- Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total OcclusionsStatus unknownNot applicableBeijing Anzhen HospitalNCT04744571Written as aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor
- Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary InterventionCompletedPhase 4Icahn School of Medicine at Mount SinaiNCT02270242Written as ticagrelor
- Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and TicagrelorCompletedPhase 4University of FloridaNCT02545933Written as Ticagrelor
- Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial AneurysmsCompletedPhase 4Beijing Neurosurgical InstituteNCT03989557Written as Aspirin and clopidogrel/Ticagrelor
- Platelet Inhibition After Pre-hospital Ticagrelor Using Fentanyl Compared to Morphine in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionCompletedNot applicableCentre Hospitalier Universitaire VaudoisNCT02531165Written as Ticagrelor
- Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary InterventionCompletedPhase 3Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyNCT02866175Written as Ticagrelor
- Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial InfarctionCompletedPhase 4University of LuebeckNCT02627950Written as Ticagrelor
- A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)TerminatedPhase 4Ottawa Heart Institute Research CorporationNCT03224923Written as Ticagrelor 60mg
- Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMIStatus unknownPhase 4University of AarhusNCT03182855Written as Ticagrelor
- Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMICompletedPhase 4Attikon HospitalNCT02943369Written as Ticagrelor 180 mg loading dose
Showing 20 of 27.
As the comparator · 15 — what is tested is compared with Ticagrelor
- Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically AloneRecruitingPhase 3Montreal Heart InstituteNCT07257198Written as Ticagrelor + aspirin
- Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 InhibitorsRecruitingPhase 4University of FloridaNCT06691191Written as Ticagrelor 90 mg
- Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary SyndromeCompletedPhase 4Vastra Gotaland RegionNCT05183178Written as Ticagrelor 90 mg
- Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial InfarctionCompletedPhase 4Faculty Hospital Kralovske VinohradyNCT03551964Written as Ticagrelor
- Influence of METHoxyflurane on ANtiplatelet Effect of Ticagrelor in Patients With Unstable Angina PectorisCompletedPhase 4Collegium Medicum w BydgoszczyNCT04442919Written as Ticagrelor alone
- Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery DiseaseCompletedPhase 4University of FloridaNCT04006288Written as ticagrelor
- Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting ConditionCompletedPhase 1University of KarachiNCT04941196Written as Brilinta (Ticagrelor 90 mg)
- TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMICompletedPhase 4The Catholic University of KoreaNCT02018055Written as Aspirin+Ticagrelor
- Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION)Status unknownPhase 4Gyeongsang National University HospitalNCT04734353Written as Ticagrelor 60mg
- Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery DiseaseCompletedPhase 4University of FloridaNCT02287909Written as Ticagrelor
- Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACSStatus unknownPhase 4East and North Hertfordshire NHS TrustNCT03775746Written as Ticagrelor 90Mg Tablet
- Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery DiseaseCompletedPhase 4Daiichi SankyoNCT01587651Written as Ticagrelor Maintenance Dose
- Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy VolunteersCompletedPhase 1Chong Kun Dang PharmaceuticalNCT03671941Written as D578
- Study of LC23-1306 in Healthy Male SubjectsCompletedPhase 1LG Life SciencesNCT01526577Written as Ticagrelor
- Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI PatientsCompletedPhase 4Sheba Medical CenterNCT02725099Written as Oral Ticagrelor
Codes
What other systems call Ticagrelor · ClinicalTrials.gg INT006735
- MeSH (NLM) D000077486TicagrelorConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) GLH0314RVCTICAGRELORConfirmed FDA, NLM, Wikidata
- RxNorm 1116632Confirmed FDA, Wikidata
- Wikidata Q420542ticagrelorConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76404TicagrelorOne source FDA
- DrugBank DB08816One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077486 | Ticagrelor | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | GLH0314RVC | TICAGRELOR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1116632 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420542 | ticagrelor | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76404 | Ticagrelor | One source FDA |
| DrugBank | DB08816 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.